Expression and Regulation of Retinoic Acid Receptors in Human Breast Cancer Cells1

Retinoic acid is known to inhibit mammary carcinogenesis in rodents and to inhibit proliferation and steroid hormone receptor gene expression in human breast cancer cells. Since these effects are likely to be mediated by nuclear retinoic acid receptors (RARs) the present study was initiated to determine the expression and regulation of RARs in human breast cancer cell lines. Differential cellular gene expression of the RARs was determined by Northern blot analysis of total RNA prepared from S IK* and 6 ER" cell lines. RARa was detected as mRNA species of 2.7 and 3.4 kilobases in all cell lines and the level of gene expression was greater in ER+ cell lines (P < 0.001). RAR0 mRNA (3.7 kilobases) was detected in seven of the eleven lines tested and was expressed most commonly in IK cell lines. RAR-ymRNA was expressed in all cell lines as a transcript of 3.4 kilobases at levels that were similar in both IK* and IK cell lines. Retinoic acid failed to regulate the expression of the RARa and RAR7 genes. The effect of steroid hormones on RARa and RAR-ymRNA levels was also examined. In four PR* cell lines (T-47D, BT 474, MCF7M, and MDA-MB-361), progestins markedly decreased RARa mRNA levels. The progestin effect on RARa levels in T-47D cells was detectable at concentrations of 0.05 UMand was maximal at 1 MM16a-ethyl-21hydroxy-19-nor-4-pregnene-3,20-dione ORG 2058, whereas dihydrotestosterone and dexamethasonc were without effect. RARa and RAR> mRNA levels were rapidly decreased by progestin, and the effect was maximal 3-6 h after ORG 2058 treatment. However, the mRNA loss was transient, and recovery of RARa and K \ K> mRNA levels was noted 12-24 h after retinoic acid treatment. Although R\Ry mRNA returned to control levels by 24 h, the decrease in RARa mRNA was maintained at around 50% control until at least 48 h. In summary, RARa and RAR-y were expressed in all human breast cancer cell lines and were regulated by progestins in the PR+ T-47D cell line. The previously reported ability of retinoic acid to down-regulate PR mRNA and the present demonstra tion that progestins down-regulate RARa and RAR-ymRNA suggest that mutual regulation may be a mechanism through which PR and the RARs interact in human breast cancer cells.

[1]  T. Bugge,et al.  Functional characterization of a natural retinoic acid responsive element. , 1991, The EMBO journal.

[2]  P. Chambon,et al.  Mouse retinoic acid receptor alpha 2 isoform is transcribed from a promoter that contains a retinoic acid response element. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[3]  J. Graham,et al.  Direct transcriptional regulation of the progesterone receptor by retinoic acid diminishes progestin responsiveness in the breast cancer cell line T-47D. , 1991, The Journal of biological chemistry.

[4]  R. Sutherland,et al.  Retinoic acid acts synergistically with 1,25-dihydroxyvitamin D3 or antioestrogen to inhibit T-47D human breast cancer cell proliferation , 1991, The Journal of Steroid Biochemistry and Molecular Biology.

[5]  M. Pfahl,et al.  Retinoic acid affects the expression of nuclear retinoic acid receptors in tissues of retinol-deficient rats. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[6]  P. Chambon,et al.  Expression of nuclear retinoic acid receptors in normal tracheobronchial cells and in lung carcinoma cells. , 1991, Experimental cell research.

[7]  P. Chambon,et al.  Multiple isoforms of the mouse retinoic acid receptor alpha are generated by alternative splicing and differential induction by retinoic acid. , 1991, The EMBO journal.

[8]  P. Chambon,et al.  Differentially expressed isoforms of the mouse retinoic acid receptor beta generated by usage of two promoters and alternative splicing. , 1991, The EMBO journal.

[9]  M. Pratt,et al.  A dominant negative mutation of the alpha retinoic acid receptor gene in a retinoic acid-nonresponsive embryonal carcinoma cell , 1990, Molecular and cellular biology.

[10]  C. Glass,et al.  Multiple cell type-specific proteins differentially regulate target sequence recognition by the α retinoic acid receptor , 1990, Cell.

[11]  George,et al.  Expression of nuclear retinoic acid receptors in wild-type and mutant embryonal carcinoma PCC4.aza1R cells. , 1990, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[12]  D. Soprano,et al.  Induction of beta-retinoic acid receptor mRNA by teratogenic doses of retinoids in murine fetuses. , 1990, Differentiation; research in biological diversity.

[13]  M. Griswold,et al.  The regulation of retinoic acid receptor mRNA levels during spermatogenesis. , 1990, Molecular endocrinology.

[14]  R. Blomhoff,et al.  Transport and storage of vitamin A , 1990, Science.

[15]  P. Chambon,et al.  Modulation by retinoids of mRNA levels for nuclear retinoic acid receptors in murine melanoma cells. , 1990, Molecular endocrinology.

[16]  J. Graham,et al.  Progesterone receptor regulation by retinoic acid in the human breast cancer cell line T-47D. , 1990, The Journal of biological chemistry.

[17]  R. Evans,et al.  Characterization of an autoregulated response element in the mouse retinoic acid receptor type beta gene. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[18]  K. Umesono,et al.  A functional retinoic acid receptor encoded by the gene on human chromosome 12. , 1990, Molecular endocrinology.

[19]  R. Evans,et al.  Nuclear receptor that identifies a novel retinoic acid response pathway , 1990, Nature.

[20]  K. Eto,et al.  Expression of retinoic acid receptor genes in neural crest‐derived cells during mouse facial development , 1990, FEBS letters.

[21]  P. Chambon,et al.  Murine isoforms of retinoic acid receptor gamma with specific patterns of expression. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[22]  J. Fontana,et al.  Retinoid modulation of estradiol-stimulated growth and of protein synthesis and secretion in human breast carcinoma cells. , 1990, Cancer research.

[23]  H. Stunnenberg,et al.  Identification of a retinoic acid responsive element in the retinoic acid receptor & beta;gene , 1990, Nature.

[24]  P. Chambon,et al.  Differential expression of genes encoding α, β and γ retinoic acid receptors and CRABP in the developing limbs of the mouse , 1989, Nature.

[25]  P. Papenhausen,et al.  Expression of retinoic acid receptor-alpha mRNA in human leukemia cells with variable responsiveness to retinoic acid. , 1989, Leukemia.

[26]  C. Siu,et al.  Retinoic acid regulation of the expression of retinoic acid receptors in wild‐type and mutant embryonal carcinoma cells , 1989, FEBS letters.

[27]  W. Blaner.  Retinol-binding protein: the serum transport protein for vitamin A. , 1989, Endocrine reviews.

[28]  P. Chambon,et al.  Cloning of murine α and β retinoic acid receptors and a novel receptor γ predominantly expressed in skin , 1989, Nature.

[29]  U. Pastorino,et al.  Liposoluble vitamins and lipid parameters in breast cancer. A joint study in northern Italy and southern France , 1988, International journal of cancer.

[30]  C. Clarke,et al.  Effect of medroxyprogesterone acetate on proliferation and cell cycle kinetics of human mammary carcinoma cells. , 1988, Cancer research.

[31]  T. Rohan,et al.  A population-based case-control study of diet and breast cancer in Australia. , 1988, American journal of epidemiology.

[32]  M. Pfahl,et al.  A new retinoic acid receptor identified from a hepatocellular carcinoma , 1988, Nature.

[33]  R. Evans,et al.  The steroid and thyroid hormone receptor superfamily. , 1988, Science.

[34]  P. Chambon,et al.  Identification of a second human retinoic acid receptor , 1988, Nature.

[35]  Pierre Chambon,et al.  A human retinoic acid receptor which belongs to the family of nuclear receptors , 1987, Nature.

[36]  V. Giguère,et al.  Identification of a receptor for the morphogen retinoic acid , 1987, Nature.

[37]  B. Henderson,et al.  Vitamin A, β-Carotene, and the Risk of Cancer: A Prospective Study , 1987 .

[38]  S. Lippman,et al.  Retinoids as preventive and therapeutic anticancer agents (Part I). , 1987, Cancer treatment reports.

[39]  O. Dapunt,et al.  Synergistic antiproliferative effect of human recombinant interferons and retinoic acid in cultured breast cancer cells. , 1986, Journal of the National Cancer Institute.

[40]  L C Murphy,et al.  Differential sensitivity of human breast cancer cell lines to the growth-inhibitory effects of tamoxifen. , 1985, Cancer research.

[41]  R. Gutell,et al.  The nucleotide sequence of a rat 18 S ribosomal ribonucleic acid gene and a proposal for the secondary structure of 18 S ribosomal ribonucleic acid. , 1984, The Journal of biological chemistry.

[42]  I W Taylor,et al.  Cell proliferation kinetics of MCF-7 human mammary carcinoma cells in culture and effects of tamoxifen on exponentially growing and plateau-phase cells. , 1983, Cancer research.

[43]  T. Byers,et al.  Diet in the epidemiology of breast cancer. , 1982, American journal of epidemiology.

[44]  M. Sporn,et al.  Can dietary beta-carotene materially reduce human cancer rates? , 1981, Nature.

[45]  M. Lippman,et al.  Binding of retinoids to human breast cancer cell lines and their effects on cell growth. , 1980, The Journal of clinical investigation.

[46]  W. Rutter,et al.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.

[47]  R. Lotan.  Different susceptibilities of human melanoma and breast carcinoma cell lines to retinoic acid-induced growth inhibition. , 1979, Cancer research.

[48]  E. L. Springer,et al.  Two syngeneic cell lines from human breast tissue: the aneuploid mammary epithelial (Hs578T) and the diploid myoepithelial (Hs578Bst) cell lines. , 1977, Journal of the National Cancer Institute.

[49]  M. Sporn,et al.  Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids). , 1976, Federation proceedings.

[50]  F. Boccardo,et al.  Phase II study of tamoxifen and high-dose retinyl acetate in patients with advanced breast cancer , 2005, Journal of Cancer Research and Clinical Oncology.

[51]  R. Mehta,et al.  Chemoprevention of mammary cancer by retinoids. , 1990, Basic life sciences.

[52]  H. Koeffler,et al.  Expression of retinoic acid receptor mRNA in hematopoietic cells. , 1990, Leukemia research.

[53]  J. Shine,et al.  Progestin inhibition of progesterone receptor gene expression in human breast cancer cells. , 1989, Molecular endocrinology.

[54]  M. Dawson,et al.  Inhibition of mammary carcinoma growth by retinoidal benzoic acid derivatives. , 1988, Experimental cell biology.

[55]  J. Fontana.  Interaction of retinoids and tamoxifen on the inhibition of human mammary carcinoma cell proliferation. , 1987, Experimental cell biology.

[56]  T. Byers,et al.  Dietary vitamin A and cancer--a multisite case-control study. , 1986, Nutrition and cancer.

[57]  C. Taylor,et al.  The effects of retinoid treatment and antiestrogens on the growth of T47D human breast cancer cells. , 1986, European journal of cancer & clinical oncology.